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Transcriptional activation of gene expression by glucocorticoid 
hormones is mediated by the interaction of hormone-receptor 
complexes with specific DNA sequences called glucocorticoid 
responsive elements (GREs) (refs 1-3, see ref. 4 for review). 
Deletion of this sequence abolishes glucocorticoid induction of 
transcription4-8. According to a current model, activation of the 
cytoplasmic receptor protein by hormone binding leads to its 
increased affinity for and translocation to the nucleus4 • However, 
recent reports that the oestradiol and progesterone receptors are 
localized in the nucleus in the absence of steroid9-11 led us to 
examine whether the free receptor interacts in vivo with its DNA 
binding site in the absence of hormone binding. We used the 
genomic footprinting techniquel 2-15 to show that changes in in vivo 
protein-DNA interactions within the GREs of the tyrosine 
aminotransferase gene (TAT) can be detected only after hormone 
treatment in hepatoma cells. Such changes are not detected in 
fibroblast cells, in which the TAT gene is not expressed. Many of 
the changes in dimethylsulphate reactivity observed in the living 
cell are also found in vitro using cloned DNA and a partially 
purified glucocorticoid receptor. 
The GREs of the rat TAT gene are located unusually far 
upstream, at -2.5 kilobases (kb), from the transcriptional start 
site (Fig. 1). These elements were initially indicated by the 
appearance of a DNasel-hypersensitive site following hormone 
treatmentl6 and then identified by gene transfer experiments 
and DNasel footprinting using partially purified glucocorticoid 
receptor complex in vitro 17 • Sequence analysis revealed several 
sequence motifs that fit the established GRE consensus 
sequence1,2,4. In this study we focus on those elements (11 and 
111, Fig. 1) that have been shown to be essential for glucocor-
ticoid induction by gene transfer experiments. 
The instability du ring purification ofthe glucocorticoid recep-
tor in the absence of ligand has hindered the analysis of its 
potential interaction with DNA sequences by in vitro methods, 
but the re cent development of the genomic footprinting tech-
niquel2,15 has made possible the analysis of receptor-DNA 
interactions in vivo in the absence of steroid. Cells of the 
TAT-expressing hepatoma cell line FTO-2B were withdrawn 
from glucocorticoids by incubation for at least 16 hours in 
serum-free medium before induction with the steroid 
dexamethasone for various times. Trypsinized cells suspended 
in medium were reacted with dimethyl sulphate (DMS) to probe 
for the reactivity of the N7 position of guanines in the major 
groove ofthe DNA p.elixI5,19,20. Patterns of guanine (G) residues 
were obtained using the probe fragment indicated in Fig. 1. 
Figure 2a shows an example of such an analysis of uninduced 
and induced FTO cells. The band intensity reflects the reactivity 
of a given guanine or a group of unresolved guanines for the 
chemical modification. Protection from methylation at guanines 
is most readily explained by protein binding whereas enhanced 
modification of guanines has been interpreted as a local increase 
in reagent concentration in a hydrophobic pocket caused by 
close contacts of protein to DNA20. Methylation protection and 
enhancement after hormone treatment were analysed quantita-
tively for each guanine (Fig. 2c). The data were collected from 
four independent experiments, each DNA sampie being ana-
lysed on at least two blots. A nu mb er of changes in band intensity 
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Fig.l The 5'-fianking region ofthe rat TAT gene. Upper line, 3 kb 
of the 5'-fianking region of the rat TAT gene: Numbering, distance 
from the cap-site; wavy arrow, the start of transcription; DIHS, 
region of dexamethasone-induced DNaseI hypersensitivity16. The 
lower line, enlargement of the region around the dexamethasone-
inducible DNaseI-hypersensitive site: black box es, sequence 
homologies to the GRE consensus sequence labelIed with roman 
numerals; arrows, single-stranded DNA probes used to generate 
genomic sequence synthesized from an M13 vector containing the 
HinfI-XbaI fragment. 
appear to be correlated with hormone treatment. DMS protec-
tions are evident at the sites of glucocorticoid interaction as 
identified by DNasel footprinting 17• Additional changes in reac-
tivity map to neighbouring sequences (see Fig. 4). In a non-
expressing rat fibroblast cell-line (XC cells) no such changes 
could be discerned after hormone treatment (Fig. 2a), nor were 
they observed when FTO-2B cells were treated with the gluco-
corticoid antagonist RU486 (Fig. 2b). 
To ascertain whether the changes in DMS reactivity observed 
in vivo at the TAT gene GREs are caused by the glucocorticoid 
receptor, we performed in vitro methylation experiments, using 
cloned TAT DNA fragments containing the GREs and a par-
tially purified glucocorticoid receptor (Fig. 3). The most promi-
nent G protections map to the conserved TGTICT motif and 
are identical with those shown to be contacted by the receptor 
in the GRE of mouse mammary tumour virus (MMTV)21. 
Figure 4 summarizes the data obtained in vivo and in vitro. 
Comparison of in vivo G reactivity patterns from uninduced 
and induced FTO-2B cells clearly shows that protection of 
guanines in the binding site is seen after dexamethasone treat-
ment of cells (Fig. 2). They are accompanied by a number of 
hormone-induced changes in reactivity in neighbouring sequen-
ces. The most dramatically enhanced G reactivities are seen at 
four adjacent guanines (-2,459 to -2,456) between the two 
receptor binding sites. Most of the changes in DMS reactivity 
following hormone treatment are also found in vitra using a 
partially purified glucocorticoid receptor. The changes are not 
found in XC cells, where the TAT gene is not transcribed. These 
findings strongly indicate that changes in reactivity at guanines 
within the GRE are indeed caused by interaction of the gluco-
corticoid receptor with its bin ding site and that its affinity in 
the absence of hormone bin ding is too low to lead to a tight 
interaction with a GRE at receptor concentrations found in the 
living cello 
Receptor binding is accompanied by changes in chromatin 
structure that ren der a region of 200 base pairs (bp) surrounding 
the GREs hypersensitive to DNasel digestionl6. Whether this 
altered structure is aprerequisite for receptor binding or rather 
a consequence of binding is not known. For the MMTV GREs 
a similar DNasel hypersensitivity has been shown to precede 
or parallel hormonal stimulation of MMTV promoter function 18. 
It should be emphasized that these effects on guanine re-
activities have been observed within a region which is unusually 
remote (at -2.5 kb) from the cap-site that is selectively rendered 
hypersensitive to DNase I digestion after dexamethasone treat-
ment. Using the same DNA sampies no hormone-dependent 
DMS effects were seen within several hundred nucleotides sur-
rounding the TAT gene cap-site or within a region of DNasel 
hypersensitivityat -l,OOObp (data not shown). Within the first 
Fig.2 Cilucocorticoid-induced changes in DMS reaetivity in vivo. 
a, Ci ladders for both strands of a region of genomie I)NA bctween 
-2,380 and -2,540 bp (upstream) of the transeriptional start site 
of the TAT gene from DMS-treated FfO-2B or XC cells (+, 
induced with dex.amethasone; -, unindueed); N, in virr(} methy-
lated protein-free DNA. Protection (6) and enhaneement (A) 
seen when comparing dexamethasone-induced with unindueed 
FfO·2B cells; numbers, distance from the cap-site. Only those 
reactivity ehanges that appeared highly signifieant in the quantita-
tive analysis (c) are indieated. *, Band originating from hybridiz-
ation to lacZ sequences on a contaminating fragment ; hatched 
bars, positions of the two major ONasel footprints obtained in 
vi/ro with partially purified glucocorticoid reeeptor". b, As in a, 
but only FfO-2B cells were used and incubation with the glueocor-
ticoid antagonist RU486 (RU) was carried out in parallel with 
dexamethasone inductions. c, Quantitative analysis of hormone-
dependent .changes in Ci methylation; summary of results. Nucleo-
tide numbers (from -2,560 10 -2,390) upstream of the TAT 
cap-site are given on the abscissa. Hatched han;, sites of reeeptor 
binding identi!ied by DNasel footprinting in vitro"; black bar, 
co.nserved hexanucleotide TGTICT. For each G residue the 
logarithm between the median o.f induced divided by the median 
of uninduced sampIes (log +dex/ -dex) is plotted . 6 and \] 
symbo.lize this value for each guanine o.n the upper and lower 
strand, respeetively. Positive values indicate dcxamethasone-
dependent enhaneements, negative values represent induciblc pro-
tections. The significance o.f the deviations obtained was checked 
by comparing induced and uninduced values using a Kruskal-
Wallis test". Those values that fell below a threshold of 5% 
prob ability of error (1st order error) are indicated with vertical 
lines. 
Methods. FfO-2B and XC eells were grown to about 80% con-
Hueney in Du!beeco's modified Eagle's medium (DMEM) eontain-
ing 10% fetal ealf-serum and 10 mM HEPES pH 7.4, withdrawn 
in serum-free DMEM for at least 16 hand ineubated for 4 h with 
serum-free DMEM with Or without 10 • M dexamethasone or 
10.6 M RU486. Induetion times were 20 min- 12 h, no significant 
time-dependent changes in the DMS rcactivity pattern were 
observed (data not shown). OMS treatment of whole cells and in 
vi/ra methylation of protein-free DNA were as published15•19 
After isolation of cellu!ar ONA, 25 I-lg of cach sampIe was restrie-
ted with HinfI (Boehringer), reaeted with piperidine and separatcd on a sequencing gel". Details of O~A blotting onto Gene Screen membrane (NEN) UV 
~rosslinking, hybridization and washing of filters were as in ref. 12. Probe synthesis from a single-stranded MI3 template was performed as dcseribcd" with 
modifieations: 100 mM NaCls was included in primer annealing and elongation reactions, 250 I-lCi of [a32PJdATP (NEN), 5,000 Ci mmole -I was used per probe 
synthesis. The newly-synthesized probe DNA was separated [rom the template strand in a 6% denaturing gel and reeovered from the polyacrylamide by 
isotaehophoresis22 Exposure times were 7-14 days with 'Iightning plus' intensifying sereens (DuPont). Quantitative analysis was done as Giniger et al."; four 
independent DMS treatments of FfO-2B dells were performcd under either dexamethasone·indueed or unindueed eonditions. The resu!ting DI'As were ana!ysed 
on a( least two independent blots. Genomie sequeneing ladders were seanned with an Elseript 400 densitometer (Fisher Scientific) at 16/Lm resolution. Peak 
integrals were ealeulated aOl'I median values determined for eaeh guanin.e band. 
Fig. 3 Changes in DMS reaetivity following glueoeorticoid reeeptor binding in vitru. Left panel, 
results obtained for the upper strand and right panel, for the lower strand with (+) and without (._) 
triameinolone-saturated glueocorticoid reeeptor. Proteeted guanines are indieatcd by open squares, 
enhanced methylation at a guanine as a filled square. Guanines that are influenced in their reactivity 
when comparing the '-' and '+' lanes are labelIed with their numbers upstream of the TAT cap-site. 
Hatehed bars, regions protected against DNaseI-digestion by bound glueocorticoid receptor in vitro l7 • 
Methods. Purification of the glueocortieoid receptoi" ineluded as a final step DEAE-Sepharose 6 
CL column chromatography in which the receptor eluted as a single peak at 150 mM NaCI. A 
Xba 1- Tth 111l fragment containing both funetional GREs was isolated from a subelone and end-
labelIed using T4 kinase polynueleotide and f'Y3Z p]ATP either at the XbaJ (upper strand) or at the 
Tth 1111 (lower strand) sites. LabelIed fragment (0.5-1.0 fmol) was incubated with (+) or without 
(-) 90 fmoles of triamcinolone-saturated receptor in a volume of 25 ~I containing 100 mM NaCI, 
0.6 mM EDTA, 7% glycerol (w/v), 22 mM Tris-CI, 1 mM MgClz, 0.5 ~g bovine serum albumin 6 mM 
ß-mercaptoethanol, 0.1 mM dithiothreitol, 1 JLM triamcinolone, 15% polyethyleneglycol 6000 
(Serva), pH 8.2. After 45 min at room temperature, 2 JLl of 10% DMS (Fluka) was added and reaction 
stopped after 2 min ineubation at room temperature by adding 75 JLl buffer containing 400 mM sodium 
acetate, 140 mM ß-mercaptoethanol and 270 JLg ml- I transfer RNA. DNA was extracted with 
phenol/chloroform (1: 1), precipitated and subjected to piperidine eleavage according to Maxam 
and Gilbert19, and finally dissolved in formamide containing loading buffer and analysed on a 6% 
sequeneing gel. 
200 bp upstream of the transcriptional start site several protee-
tions and enhancements can bc identified that are strictly corre-
lated with the active state of the gene in FTO-2B cells but are 
not seen in XC cells. However, none of them are influenced by 
hormone treatment (P.B., unpublished data). 
Comparison of the methylation patterns of the two analysed 
GREs in vivo reveals qualitative and quantitative differences . 
Whereas the protection of the central guanine (-2,499) in ele-
ment II is c1early evident, it is less prominent in element III 
(-2,436). A surprising finding is a very strong proteetion of a 
TGT (-2,432) upstream of the conserved hexanucleotide 
TGTICT of GRE IU. Why the two binding siles behave so 
differently is not known. Recent results suggest that this 
difference in DMS reactivities might reflect ditferences in the 
~M" "" ).~ T""T<'<>C<"~ TC="'C'~ ~ .. ,,~,c<;,c<; '~,,,,:.cc<:,C 
1:'111.4 Summary of results obtained by DMS reactivity e~lX'ri· 
ments in t;ivo and in vi/ro. Changes in DMS reactivity at guanines 
in the DNA sequenee betwecn nuc1eotidcs - 2,521 and - 2,382, 
upstream of the TAT cap-site, are shown. Hatched bars. sites of 
glucoeonicoid receptor interaction as identified by in V;lrQ foot-
printing e~periments l7. Filled sYß].bols, G residues showing 
enhanced methylation; open symbols, guanines showing protec· 
tion~ from methylat ion. Squares. in vitro dala; triangles, 
de~amethasone·depcndenl changes in vivo; half-ci rc1es. changes 
in reactivity found in vivo eomparing the pattern obtained from 
uninduced cells with that from protein-free DNA. rar the irr vioo 
data only those guanines are indicated thaI by quantitative analysis 
have heen shown to bc signifieantly innuenced in thei r reactivity 
(Fig.2.-). 
inducing eapaci ty of the two GREs (M. Janlzen and U.s. , 
unpublished data ), 
In addit ion to eHeets in the reeeptor binding site, a nu mber 
of changes in reactivity are observed in neighbouring seq uenccs 
after de~amethasone treatment. Most prominent among these 
a re Ihe enhaneements of guanines at - 2,5 15, - 2,45910 - 2,456, 
and at -2,424 and proleetions of guanines al - 2,475, "2,402 10 
- 2,400, --2.396, and - 2,395, in vivo and 10 some e~ tenl in vi/rOT 
Whelher these changes are due to alteratio lls in DNA St rueture 
as a consequence of gl ucocorticoid reeeptor bi nding or inle rac-
tiOrt with other factors not yel defined remai ns unclea r. 
These changes in DMS reactivity are clearly correlated with 
hon;none induction and OIher changes are evident when the 
pattern of DMS reacti vi ty of uninduced FrO-2B cell chromatin 
is compared wi th that ofprotein·free fTO -28 DNA (quantitat ive 
allalysis not shown). Analysis of the reactivity of single guanines 
in naked genomic DNA at various sites and in plasmid IJ NA 
revealed thaI guanines llanked by Ihymidines or fo llowed by a 
thymidine are oflen unusually sensit ive to melhylation, This 
enhanced reaclivity is not observed in vioo. which might he 
explained by the differente in reaction conditi ons inside living 
cells compared wilh protein.frec IJNA i/I vi/ra. Because ofthese 
differences in methylation conditions naked genomic DNA can-
not serve as a suitable standard fo r comparisons of DMS re-
act ivity obta ined in vivo. The methylation patte rn in uninduced 
FrO-cells is identical to that obtaillcd from induced or un-
induced XC-cells. In contrast to observations at the cap-site, 
there is no evidence for an interaction of protein factors with 
the receptor binding si te in the absence ofhormone thaI discri mi -
nales TAT in FrO-cells from the gene in nonexpressing fibro-
blast cells. 
We have applied genomic sequencing methodology to obtain 
information on the in vivQ interaction of thc glucocorticoid 
reeeplor with its recognition sequence in the TAT gene. Resul ts 
suppon the concept that gl ucocon icoid increases the afl inity of 
the reeeptor for its target sequence. These e~periments do not 
exd ude Ihe possibility that the unliganded receptor can interal'l 
with a GRE. albeil wi th lower aflinit y and selectivity. 
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